- This event has passed.
Developments in Cannabinoid Medicines
13 March @ 5:00 pm - 7:30 pm GMT
Cannabis has been used as a medicine for thousands of years. Internationally the laws governing the medical and non-medical use of cannabis and cannabinoids (the chemical constituents of cannabis) are rapidly evolving. In this lecture Dr Michael Bloomfield will explain what a cannabinoid is, how cannabinoids act on the body and will give an overview of current research on cannabinoid medicines.
Dr Bloomfield is a UCL Excellence Fellow. He leads the Translational Psychiatry Research Group and is an Honorary Consultant Psychiatrist at the Traumatic Stress Clinic in London. He studied Natural Sciences specializing in neuroscience, pharmacology and psychology, at Corpus Christi College, Oxford. He then studied Clinical Medicine at Oxford. He began his clinical Psychiatry training on the Charing Cross rotation, where he worked at Charing Cross and Chelsea & Westminster Hospitals. He was then appointed a Medical Research Council Clinical Research Fellow at the Imperial College London Institute of Clinical Sciences in Hammersmith Hospital. Michael’s research seeks to understand the mechanisms underlying how exposure to risk factors for mental illness during childhood and adolescence alter brain and cognitive function to give rise to mental illnesses so that new treatment and preventative interventions can be developed. He has been awarded young investigator prizes from major national and international research societies. He has published over 40 papers in peer-reviewed journals, including Nature, and has a co-authored book chapter for the Oxford Textbook of Psychosis currently in press.